PRGO buys US rights to AZN’s Entocort (for Crohn’s disease) for $380M: http://www.reuters.com/article/2015/11/23/astrazeneca-ma-perrigo-idUSL8N13I0OU20151123#5ryF3uvqPkJj5sJk.97 AZN had previously divested the ex-US rights to this drug.